Journal of Clinical Medicine· 2026Q2
Remimazolam Versus Dexmedetomidine for Monitored Anesthesia Care in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Randomized Clinical Trial
- 0citations
- Q2SCImago
- 2026year
Short summary
Remimazolam led to faster recovery (13.5 min vs. 32.4 min) and fewer surgeon requests for deeper sedation (11.8% vs. 76.5%) compared to dexmedetomidine in patients undergoing transfemoral transcatheter aortic valve implantation (tf-TAVI).
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Cardiology and Cardiovascular Medicine
Cardiology and Cardiovascular MedicineMedicine